Home > PE Ratio > ERIS LIFESCIENCES

ERIS LIFESCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of ERIS LIFESCIENCES is 32.04.

Share Price ₹892.6Apr 26,2024
Market Cap ₹12,139.4 Cr
Earnings-TTM₹378.9 CrTTM-Consolidated Results
Price/Earnings32.04xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ERIS LIFESCIENCES is calculated as :

Current Market Cap [ ₹12,139.4 Cr] as on Apr 26,2024

(/) Earnings [ ₹378.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 32.04x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 32.04 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES


PE Ratio Performance Analysis for ERIS LIFESCIENCES

- ERIS LIFESCIENCES 's latest p/e ratio is 32.04x.

- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 22.77x.

- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.06x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2019 at 30.46x.

- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2020 of 16.88x.


How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ERIS LIFESCIENCES 378.9032.0412,139.4
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.11360,920.0
CIPLA LTD3,744.0330.39113,794.0
DR REDDYS LABORATORIES LTD5,209.4020.02104,316.0
ZYDUS LIFESCIENCES LTD2,954.2032.2995,380.9
DIVIS LABORATORIES LTD1,382.9777.27106,860.0
MANKIND PHARMA LTD1,743.3054.4294,869.4
TORRENT PHARMACEUTICALS LTD1,494.0060.9591,057.0
LUPIN LTD1,809.7440.6973,642.4
AUROBINDO PHARMA LTD2,777.8923.8666,278.5
ABBOTT INDIA LTD1,145.5847.9854,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.02x
Max industry PE 77.27x
Median industry PE 40.11x
Average industry PE 41.82x



You may also like the below Video Courses